Christelle Clément-Duchêne

Summary

Publications

  1. ncbi [Anti-angiogenic agents in the treatment of lung cancer: indications and toxicities]
    C Clément-Duchêne
    Service de Pneumologie, CHU de Nancy, Allee du Morvan, Vandœuvre lès Nancy, France
    Rev Mal Respir 29:161-77. 2012
  2. ncbi Characteristics of never smoker lung cancer including environmental and occupational risk factors
    Christelle Clément-Duchêne
    Respiratory Diseases Department, University Hospital, Vandoeuvre les Nancy, France
    Lung Cancer 67:144-50. 2010
  3. ncbi [Protocols for lung cancer screening: Limitations, and consequences]
    C Clément-Duchêne
    Service de Pneumologie, Hopital de Brabois, CHU de Nancy, allée du Morvann, 54511 Vandoeuvre les Nancy, France
    Rev Mal Respir 27:314-28. 2010
  4. ncbi How accurate are physicians in the prediction of patient survival in advanced lung cancer?
    Christelle Clément-Duchêne
    Service de Pneumologie, Hopital de Brabois, CHU de Nancy, 54511 Vandoeuvre les Nancy, France
    Oncologist 15:782-9. 2010
  5. ncbi [Diagnostic accuracy of endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal lymph nodes]
    Guillaume Gauchotte
    Laboratoire de Pathologie, Hopital Central, CHU de Nancy, 29, Avenue du Marechal de Lattre de Tassigny, 54000 Nancy, France
    Ann Pathol 31:142-51. 2011

Detail Information

Publications5

  1. ncbi [Anti-angiogenic agents in the treatment of lung cancer: indications and toxicities]
    C Clément-Duchêne
    Service de Pneumologie, CHU de Nancy, Allee du Morvan, Vandœuvre lès Nancy, France
    Rev Mal Respir 29:161-77. 2012
    ..This article will review these new-targeted anti-angiogenic agents with a focus on their use in lung cancer and on their important side effects...
  2. ncbi Characteristics of never smoker lung cancer including environmental and occupational risk factors
    Christelle Clément-Duchêne
    Respiratory Diseases Department, University Hospital, Vandoeuvre les Nancy, France
    Lung Cancer 67:144-50. 2010
    ..Clinical characteristics and risk factors of nonsmoker patients with lung cancer are still debated...
  3. ncbi [Protocols for lung cancer screening: Limitations, and consequences]
    C Clément-Duchêne
    Service de Pneumologie, Hopital de Brabois, CHU de Nancy, allée du Morvann, 54511 Vandoeuvre les Nancy, France
    Rev Mal Respir 27:314-28. 2010
    ..Only few trials have studied the consequences of lung cancer screening on the quality of life. In this review, we analyze the various screening strategies, their impact on quality of life and health and their adverse effects...
  4. ncbi How accurate are physicians in the prediction of patient survival in advanced lung cancer?
    Christelle Clément-Duchêne
    Service de Pneumologie, Hopital de Brabois, CHU de Nancy, 54511 Vandoeuvre les Nancy, France
    Oncologist 15:782-9. 2010
    ..The aim of this study was to assess the accuracy of clinicians' predictions of survival in NSCLC patients (stages IIIB, and IV) and the possible impact of patient quality of life on survival estimation...
  5. ncbi [Diagnostic accuracy of endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal lymph nodes]
    Guillaume Gauchotte
    Laboratoire de Pathologie, Hopital Central, CHU de Nancy, 29, Avenue du Marechal de Lattre de Tassigny, 54000 Nancy, France
    Ann Pathol 31:142-51. 2011
    ..Because it allows collecting only a small amount of materiel, an optimal processing of the samples is needed...